Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Giuseppe Procopio
Association of Systemic Inflammation Index and Body Mass Index With Survival in Patients With Renal Cell Cancer Treated With Nivolumab
Clinical Cancer Research
Cancer Research
Oncology
Real-World Efficacy and Safety of Nivolumab in Previously-Treated Metastatic Renal Cell Carcinoma, and Association Between Immune-Related Adverse Events and Survival: The Italian Expanded Access Program
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Bone Health Management in the Continuum of Prostate Cancer Disease: A Review of the Evidence With an Expert Panel Opinion
ESMO Open
Cancer Research
Oncology
Predictors of Long-Term Response to Abiraterone in Patients With Metastastic Castration-Resistant Prostate Cancer: A Retrospective Cohort Study
Oncotarget
Oncology
The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Clinical Experience With Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
Personalized Therapy in Renal Cell Carcinoma: Are the Different Tyrosine Kinase Inhibitors the Same for Any Patient?
Expert Review of Precision Medicine and Drug Development
Molecular Medicine
Drug Discovery
Genetics
Pharmacology
Evolution and Innovations in the Systemic Treatment Landscape of Renal Cell Carcinoma
Cancer Breaking News
Costo-Efficacia Di Cabozantinib Nel Trattamento Di Seconda Linea Del Tumore a Cellule Renali Metastatico (mRCC) in Italia
Global and Regional Health Technology Assessment
Health Policy
Gemcitabine Plus Vinorelbine as First-Line Chemotherapy in Advanced Nonsmall Cell Lung Carcinoma a Phase II Trial
Cancer
Cancer Research
Oncology
1
2
›
